C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
12/2011
12/22/2011	US20110311449 Antibodies
12/22/2011	CA2802376A1 Anti-vegf antibodies and uses thereof
12/22/2011	CA2802360A1 Nuclease activity of tal effector and foki fusion protein
12/22/2011	CA2802351A1 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures
12/21/2011	EP2397555A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
12/21/2011	EP2397547A1 Drug transporter, and adjuvant and vaccine each utilizing same
12/21/2011	EP1485492B1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
12/21/2011	CN102292102A 免疫应答的引发 Eliciting an immune response
12/21/2011	CN102286107A 一种高效表达重组丙型肝炎病毒多表位抗原的方法和应用 An efficient expression of recombinant hepatitis C virus multi-epitope approach and application
12/21/2011	CN102286106A 夹心外膜蛋白展示载体及应用其制备的大肠埃希菌疫苗 Sandwich outer membrane protein of Escherichia coli display vector vaccine preparation and application of
12/21/2011	CN102286105A 芝麻蛋白源金属螯合肽与肽微量元素螯合物及其应用 Sesame protein source, metal chelating peptides and peptide chelates of trace elements and its application
12/21/2011	CN102286104A Hpv6型l2n120e7e6融合蛋白基因、表达载体、方法、菌株和用途 Hpv6 type l2n120e7e6 fusion protein gene, expression vectors, methods, and uses of the strain
12/21/2011	CN102286077A T细胞表位肽 T cell epitope peptide
12/21/2011	CN102286074A 一种cd13靶向肽ngr及其应用 One kind cd13 ngr targeting peptide and its application
12/21/2011	CN101633698B 一种免疫融合蛋白及其编码基因与应用 A protein coding gene and application of immunological fusion
12/20/2011	US8080636 BSL3 antibodies
12/20/2011	US8080388 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/20/2011	US8080254 OB fusion protein compositions and methods
12/20/2011	CA2329754C Peptide composition as immunogen for the treatment of allergy
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	WO2011156751A2 Immunogenic vaccine
12/15/2011	WO2011153965A1 Fusion protein of exendin-4 and its analog, preparation method and use thereof
12/15/2011	WO2011153763A1 Mixture of t cell immune balance peptides
12/15/2011	WO2011153642A1 Leptin and leptin analog conjugates and fusion proteins and uses thereof
12/15/2011	US20110306044 Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereof
12/15/2011	US20110305723 Molecular Antigen Array
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305718 Recombinant Protein Body-Inducing Polypeptides
12/15/2011	US20110305716 Targeted cytokine for treatment of diseases
12/15/2011	US20110305712 Ctla4 proteins and their uses
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305697 Fc fusion proteins
12/15/2011	US20110305696 anti-serum albumin binding variants
12/15/2011	US20110305695 Wnt Antagonists and Methods of Treatment and Screening
12/15/2011	US20110305694 Multivalent and/or multispecific rankl-binding constructs
12/15/2011	US20110305693 Anitigen-binding constructs
12/15/2011	US20110305663 Serum albumin binding molecules
12/15/2011	CA2800911A1 Immunogenic vaccine
12/14/2011	EP2395014A2 Silk proteins
12/14/2011	EP1888641B1 Serum albumin binding proteins
12/14/2011	CN102282176A 由母体全血进行非侵入性胎儿RhD基因型分型 Maternal whole blood by a non-invasive fetal RhD genotyping
12/14/2011	CN102277381A 一种重组蛋白的制备方法及其应用 Preparation of a recombinant protein and its application
12/14/2011	CN102277364A 融合蛋白LhFVII-LDP和强化融合蛋白LhFVII-LDP-AE及其应用 The fusion protein LhFVII-LDP and strengthen the fusion protein LhFVII-LDP-AE and its application
12/14/2011	CN102276731A 抑制可卡因诱发的高运动活性的多肽及其应用 Suppression of cocaine-induced locomotor activity in polypeptides and their high application
12/14/2011	CN102276730A 金黄色葡萄球菌IsdB<sub>id</sub>-TRAP融合蛋白制备方法及其应用 Staphylococcus aureus IsdB <sub> id </ sub> -TRAP fusion protein preparation method and its application
12/14/2011	CN102276729A 抗菌肽lf-th及其大肠杆菌重组制备方法 Antimicrobial peptides lf-th and E. coli recombinant preparation
12/14/2011	CN102276728A 以Bt蛋白Bt886-cry3Aa为基础的融合蛋白及其用途 Bt protein to Bt886-cry3Aa based fusion proteins and their use
12/14/2011	CN102276727A IL-17RC-hFc融合蛋白及其应用 IL-17RC-hFc fusion protein and its application
12/14/2011	CN102276726A 肝细胞生长因子受体活性基团的融合蛋白 Hepatocyte growth factor receptor fusion protein reactive groups
12/14/2011	CN102276725A 隐孢子虫CTL和Th混合多表位基因和融合蛋白及应用 Cryptosporidium CTL and Th mixed multi-epitope genes and fusion proteins and application
12/14/2011	CN102274496A 一种O/Asia I型口蹄疫病毒两价基因工程多肽疫苗及制备方法和用途 One kind of O / Asia I FMDV two price genetically engineered peptide vaccine and preparation and use
12/14/2011	CN101805408B 抗肿瘤溶栓双效嵌合蛋白及其制备方法和应用 Anti-tumor effect of thrombolytic double chimeric protein and its preparation method and application
12/14/2011	CN101434656B Opg-hsp70融合蛋白的制备方法及用途 Opg-hsp70 fusion protein preparation and use
12/13/2011	US8076449 polypeptide containing an amino acid sequence represented by Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Pro-Ala-Gly-Ala-Ser-Arg-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro; or having a deletion, substitution, insertion of above sequence or modified polypeptide; Alzheimer's disease, amyotrophic lateral sclerosis
12/13/2011	US8076096 Alteration of cell membrane with FasL
12/13/2011	US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/13/2011	CA2475821C Group b streptococcus antigens
12/13/2011	CA2452806C Water-soluble stabilized self-assembled polyelectrolytes
12/13/2011	CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/08/2011	WO2011153522A2 Compounds and methods for fret based measurement of enzyme activity
12/08/2011	WO2011153276A2 Stable, functional chimeric cellobiohydrolase class i enzymes
12/08/2011	WO2011152694A2 Fusion protein having factor vii activity
12/08/2011	WO2011150470A1 Vitronectin:keratinocyte growth factor chimeras
12/08/2011	WO2011097527A9 Immunoprotection of therapeutic moieties using enhanced fc regions
12/08/2011	WO2011053991A3 Vault complexes for cytokine delivery
12/08/2011	US20110301339 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301338 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301337 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301334 Cysteine engineered antibodies and conjugates
12/08/2011	US20110301073 Novel DNA-binding proteins and uses thereof
12/08/2011	US20110300629 TRAIL trimers, methods and uses therefor
12/08/2011	US20110300578 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300577 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300172 Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
12/08/2011	US20110300141 Novel Alphabeta-Binding protein and its peptide derivatives and uses thereof
12/08/2011	US20110300099 Multi-level specific targeting of cancer cells
12/08/2011	CA2801240A1 Vitronectin:keratinocyte growth factor chimeras
12/08/2011	CA2801223A1 Fusion protein having factor vii activity
12/08/2011	CA2800281A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	CA2796189A1 Stable, functional chimeric cellobiohydrolase class i enzymes
12/07/2011	EP2392596A2 Intrabodies with defined framework that is stable in a reducing environment and applications thereof
12/07/2011	EP2391655A1 Hybridization linkers
12/07/2011	EP1294770B1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
12/07/2011	EP1141248B1 A method for the high level expression of the active form of lymphotoxin-beta receptor immunoglobulin fusion proteins and their purification
12/07/2011	CN102272304A 切断固醇侧链的酶蛋白质及其应用 Sterol side chain enzymes cut the protein and its application
12/07/2011	CN102272163A 瘦素和瘦素类似物结合物及其用途 Leptin and analogue conjugates and their use
12/07/2011	CN102272159A 结合SPARC的ScFc Combination of SPARC ScFc
12/07/2011	CN102268094A Modified transferrin fusion proteins
12/07/2011	CN102268093A 一种肝靶向肽与人干扰素a2b融合蛋白及其制备方法和应用 One kind of liver targeting peptide fusion protein with human interferon a2b its preparation method and application
12/07/2011	CN101602809B 具有抗炎作用的抗体靶向补体抑制物 Antibody targeted complement inhibitors have anti-inflammatory effects
12/06/2011	US8071747 Fusion proteins of mycobacterium tuberculosis
12/06/2011	US8071742 Method and composition for crystallizing G protein-coupled receptors
12/06/2011	US8071539 Albumin fusion proteins
12/06/2011	US8071538 Method of increasing muscle mass by administering a myostatin binding agent
12/06/2011	US8071328 Bioluminescent protease assay
12/06/2011	US8071110 Activatable clostridial toxins
12/06/2011	CA2512933C A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
12/06/2011	CA2345287C Tgf-beta superfamily mutant members, including morphogenic proteins
12/01/2011	WO2011149493A1 Single -chain variable fragment anti-cd133 antibodies and uses thereof

1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 295